Projects

International

• Collaboration on a complex pharmacological assessment of inflammatory diseases of the musculo-skeletal system and gastrointestinal tract on experimental animal models
  Program: Bilateral - other
  Duration: 1. 1. 2019 – 31. 12. 2022

• Anti-inflammatory effect of astaxanthin, sulforaphane and Crocus sativus extract evaluated in two rodent models of age related diseases.
  Program: Inter-academic agreement
  Duration: 1. 1. 2018 – 30. 6. 2021

• Targeting Molecular Pathways of Glucolipotoxicity by a Novel Carboxymethylated Mercaptotriazinoindole Inhibitor of Aldo-Keto Reductase AKR1B1 In Diabetes, Inflammation and Age-related Neurodegeneration
  Program: Bilateral - other
  Duration: 1. 5. 2016 – 30. 4. 2019

National

• Preparation and quality control of modern dosage forms for alternative administration rout of biologics by inhalation (APVV-23-0508)
  Program: SRDA
  Duration: 1. 7. 2024 – 30. 6. 2028

• In vitro study of antioxidative/antiinflammatory effects of natural and synthetic compounds. In vivo assessment of medicinal effects of selected compounds in experiments of healing skin wounds.
  Program: VEGA
  Duration: 1. 1. 2023 – 31. 12. 2027

• Neuroprotective and cardioprotective potential of phenol acids in the prevention of civilization diseases
  Program: VEGA
  Duration: 1. 1. 2023 – 31. 12. 2026

• Gut microbiota and diabetic peripheral neuropathy: effect of cemtirestat in rat models of diabetes
  Program: SRDA
  Duration: 1. 7. 2020 – 30. 6. 2024

• -
  Program: VEGA
  Duration: 1. 1. 2020 – 31. 12. 2023

• Effect of fructose diet in experimental models of metabolic syndrome and in healthy subjects: proposal of effective pharmacological treatment
  Program: VEGA
  Duration: 1. 1. 2019 – 31. 12. 2022

• -
  Program: VEGA
  Duration: 1. 1. 2019 – 31. 12. 2021

• -
  Program: SRDA
  Duration: 1. 7. 2016 – 30. 6. 2020

• -
  Program: VEGA
  Duration: 1. 1. 2015 – 31. 12. 2018